This compound is a pharmaceutical impurity reference standard used for analytical testing and quality control in drug development. It is structurally characterized as a chloro-propanone derivative of a pyrazolopyrimidine scaffold, with multiple aromatic rings and an ether linkage.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1288338-96-4
1-((R)-3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-((S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one
pharmaceutical reference standard impurity
Ibrutinib, (S)-
active pharmaceutical ingredient
Tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
n.a
1-(phenylsulfonyl)-1H-indol-3-ylboronic acid
boronic acid building block
4,4'-(Ethyne-1,2-diyl)diphthalic Anhydride
chemical intermediate for advanced materials
1,3-bis(2,2-difluoropropanoyloxy)propan-2-yl 2-methylprop-2-enoate
Polymerizable monomer for coatings
3,4,5-Trifluoro-4'-(trans-4-propylcyclohexyl)-1,1'-biphenyl
liquid crystal intermediate
Ibrutinib acetyl impurity
n.a
1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one
VJQOEGZWPHTCTQ-GOSISDBHSA-N
C1C[C@H](CN(C1)C(=O)CCCl)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N